G01N 33/68
Involving proteins, peptides or amino acids
Official title: involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)}
G01N33/68 (Involving proteins, peptides or amino acids) appears on 19,518 US grants and 36,057 published applications in this corpus.
Search patents in G01N- Granted patents
- 19,518
- Published applications
- 36,057
- Assignees
- 9,489
- Inventors
- 58,864
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 5 | 0 |
| 1978 | 3 | 0 |
| 1979 | 8 | 0 |
| 1980 | 10 | 0 |
| 1981 | 12 | 0 |
| 1982 | 11 | 0 |
| 1983 | 12 | 0 |
| 1984 | 19 | 0 |
| 1985 | 28 | 0 |
| 1986 | 19 | 0 |
| 1987 | 42 | 0 |
| 1988 | 39 | 0 |
| 1989 | 56 | 0 |
| 1990 | 54 | 0 |
| 1991 | 54 | 0 |
| 1992 | 88 | 0 |
| 1993 | 127 | 0 |
| 1994 | 105 | 0 |
| 1995 | 124 | 0 |
| 1996 | 155 | 0 |
| 1997 | 226 | 0 |
| 1998 | 390 | 0 |
| 1999 | 306 | 0 |
| 2000 | 302 | 0 |
| 2001 | 354 | 116 |
| 2002 | 350 | 808 |
| 2003 | 318 | 1769 |
| 2004 | 317 | 1108 |
| 2005 | 330 | 1226 |
| 2006 | 490 | 1271 |
| 2007 | 509 | 1109 |
| 2008 | 465 | 1064 |
| 2009 | 463 | 1221 |
| 2010 | 659 | 1397 |
| 2011 | 660 | 1388 |
| 2012 | 623 | 1205 |
| 2013 | 745 | 1702 |
| 2014 | 776 | 1609 |
| 2015 | 814 | 1563 |
| 2016 | 814 | 1629 |
| 2017 | 924 | 1528 |
| 2018 | 939 | 1537 |
| 2019 | 955 | 1646 |
| 2020 | 976 | 1679 |
| 2021 | 918 | 1711 |
| 2022 | 865 | 1699 |
| 2023 | 805 | 1579 |
| 2024 | 810 | 1713 |
| 2025 | 844 | 1608 |
| 2026 | 592 | 1172 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- G01N 33/6893Related to diseases not provided for elsewhere6,543
- G01N 33/6803General methods of protein analysis not limited to specific proteins or families5,398
- G01N 33/6854Immunoglobulins2,427
- G01N 33/6872Intracellular protein regulatory factors and their receptors1,753
- G01N 33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell1,698
- G01N 33/6887From muscle, cartilage or connective tissue771
- G01N 33/689Related to pregnancy or the gonads655
- G01N 33/6875Nucleoproteins379
All 11 subgroupsShow fewer
Recent patents
- Compositions, methods and kits for treating complement related disorders6 Oct 2026US 12,751,993 B2Trustees of Tufts College
- Peptide libraries with non-canonical amino acids6 Oct 2026US 12,753,205 B2Regeneron Pharmaceuticals, Inc.
- ß-amyloid cyclic ribonucleic acid, polypeptide, and application thereof6 Oct 2026US 12,753,215 B2
- Bioactive agents and methods related thereto6 Oct 2026US 12,753,216 B2Aroa Biosurgery Limited
- Anti-ABCG2 antibodies and uses thereof6 Oct 2026US 12,753,241 B2William Robert Arathoon Living Trust Dated August 29, 2016
- Methods of determining glucose hypometabolism-induced energy crisis and treatments thereof8 Oct 2026US 2026/0306018 A1Senovia Biosciences LLC
- Methods for using bacteria and host/microbiota-derived metabolites for diagnosis and treatment of endometriosis8 Oct 2026US 2026/0306451 A1Baylor College of Medicine
- Composition, methods and uses8 Oct 2026US 2026/0306509 A14E Therapeutics, Inc.
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Psma specific binding proteins for cancer diagnosis and treatment8 Oct 2026US 2026/0306582 A1Navigo Proteins GmbH
Most cited
By later US patents
- Interleukin-1α antibodies1,029US 8,034,337 B2Xbiotech, Inc. · 2011
- Method and device for detecting and quantifying glucose in body fluids905US 5,342,789 ASensor Technologies, Inc. · 1994
- Methods for producing members of specific binding pairs893US 5,969,108 ACambridge Antibody Technology Limited · 1999
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Patient classification703US 6,763,307 B2Bioseek, Inc. · 2004